{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T18:48:05Z","timestamp":1789325285272,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-25075-z","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T12:57:11Z","timestamp":1762779431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Time to death and its associated factors among tuberculosis patients undergoing directly observed therapy at Butajira General Hospital: using accelerated failure time model"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0180-9669","authenticated-orcid":false,"given":"Buzuneh Tasfa","family":"Marine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muksina Ahmed","family":"Agago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihiret Genene","family":"Zewde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"25075_CR1","unstructured":"Lee H, Kim J, Choi H. Review on global burden of tuberculosis in 2022. 2024."},{"key":"25075_CR2","unstructured":"Netthong R et al. An updated bibliometric analysis of tuberculosis research in ASEAN countries: 2000\u20132024. Interprofessional J Health Sci. 2024;22(2)."},{"key":"25075_CR3","unstructured":"Organization WH. Tuberculosis preventive treatment: rapid communication. World Health Organization. 2024."},{"issue":"1","key":"25075_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s40592-024-00189-z","volume":"42","author":"V Prasad","year":"2024","unstructured":"Prasad V, Haslam A. COVID-19 vaccines: history of the pandemic\u2019s great scientific success and flawed policy implementation. Monash Bioeth Rev. 2024;42(1):28\u201354.","journal-title":"Monash Bioeth Rev"},{"issue":"5","key":"25075_CR5","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1016\/S2352-3018(25)00074-8","volume":"12","author":"D Ten Brink","year":"2025","unstructured":"Ten Brink D, et al. Impact of an international HIV funding crisis on HIV infections and mortality in low-income and middle-income countries: a modelling study. Lancet HIV. 2025;12(5):e346\u201354.","journal-title":"Lancet HIV"},{"issue":"2","key":"25075_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/17476348.2020.1694907","volume":"14","author":"AD Harries","year":"2020","unstructured":"Harries AD, et al. Treatment for latent tuberculosis infection in low-and middle-income countries: progress and challenges with implementation and scale-up. Expert Rev Respir Med. 2020;14(2):195\u2013208.","journal-title":"Expert Rev Respir Med"},{"key":"25075_CR7","unstructured":"Organization WH. WHO civil society task force on tuberculosis. Engagement with civil society as a driver for change: progress report 2022\u20132023. World Health Organization. 2024."},{"issue":"1","key":"25075_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1142-2","volume":"15","author":"D Fiseha","year":"2015","unstructured":"Fiseha D, Demissie M. Assessment of directly observed therapy (DOT) following tuberculosis regimen change in Addis Ababa, Ethiopia: a qualitative study. BMC Infect Dis. 2015;15(1):405.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"25075_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08533-0","volume":"23","author":"TG Wondmeneh","year":"2023","unstructured":"Wondmeneh TG, Mekonnen AT. The incidence rate of tuberculosis and its associated factors among HIV-positive persons in Sub-Saharan Africa: a systematic review and meta-analysis. BMC Infect Dis. 2023;23(1):613.","journal-title":"BMC Infect Dis"},{"key":"25075_CR10","unstructured":"Gelaw Y. Towards sustainable TB control in Ethiopia\u2013profiling high-risk geographical areas using spatial modelling. 2020."},{"issue":"1","key":"25075_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-10-462","volume":"10","author":"D Biffa","year":"2010","unstructured":"Biffa D, Bogale A, Skjerve E. Diagnostic efficiency of abattoir meat inspection service in Ethiopia to detect carcasses infected with Mycobacterium bovis: implications for public health. BMC Public Health. 2010;10(1):462.","journal-title":"BMC Public Health"},{"issue":"1","key":"25075_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-10-651","volume":"10","author":"MK Gebremariam","year":"2010","unstructured":"Gebremariam MK, Bjune GA, Frich JC. Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study. BMC Public Health. 2010;10(1):651.","journal-title":"BMC Public Health"},{"key":"25075_CR13","doi-asserted-by":"crossref","unstructured":"Tolosie K, Sharma M. Application of cox proportional hazards model in case of tuberculosis patients in selected addis ababa health centres, ethiopia. Tuberculosis research and treatment. 2014;2014.","DOI":"10.1155\/2014\/536976"},{"issue":"1","key":"25075_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4018\/IJBCE.2015010101","volume":"4","author":"FZ Chere","year":"2015","unstructured":"Chere FZ, Tesfay YY, Enquoselassie F. Parametric survival modelling of risk factor of tuberculosis patients under DOTS program at Hawassa Town, Ethiopia. Int J Biomedical Clin Eng (IJBCE). 2015;4(1):1\u201317.","journal-title":"Int J Biomedical Clin Eng (IJBCE)"},{"issue":"12","key":"25075_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144244","volume":"10","author":"A Birlie","year":"2015","unstructured":"Birlie A, et al. Time to death and associated factors among tuberculosis patients in Dangila Woreda, Northwest Ethiopia. PLoS ONE. 2015;10(12):e0144244.","journal-title":"PLoS ONE"},{"key":"25075_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-016-3557-0","volume":"16","author":"Y Beyene","year":"2016","unstructured":"Beyene Y, Geresu B, Mulu A. Mortality among tuberculosis patients under DOTS programme: a historical cohort study. BMC Public Health. 2016;16:1\u20136.","journal-title":"BMC Public Health"},{"key":"25075_CR17","unstructured":"Ashenafi Senbeta AS, Goitom Weldegerima GW, Gebremedhin GR, Romha. Survival analysis and associated risk factors of tuberculosis in-hospital patients\u2019 death in Hawassa city and at Yirgalem town health centers. 2014."},{"issue":"1","key":"25075_CR18","first-page":"2","volume":"7","author":"D Fantaw","year":"2018","unstructured":"Fantaw D, et al. Assessment of the survival status and risk factors for the mortality among multidrug resistant tuberculosis patients at Adama and Bishoftu general hospitals, Oromia, ethiopia: a retrospective cohort study. Adv Pharmacoepidemiol Drug Saf. 2018;7(1):2\u20135.","journal-title":"Adv Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"25075_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4236\/ojpm.2022.1210017","volume":"12","author":"G Teketelew","year":"2022","unstructured":"Teketelew G, Medhin G, Fenta TG. Survival and its predictors among tuberculosis patients on treatment in selected health centers of Addis Ababa, Ethiopia: a retrospective cohort study. Open J Prev Med. 2022;12(10):223\u201338.","journal-title":"Open J Prev Med"},{"key":"25075_CR20","unstructured":"Enquoselassie F. Parametric Survival Modelling of Risk Factor of Tuberculosis Patients under DOTS Program at Hawassa Town, Ethiopia. 2015."},{"key":"25075_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-11-127","volume":"11","author":"B Getahun","year":"2011","unstructured":"Getahun B, et al. Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTS programme in addis Ababa, Ethiopia. BMC Infect Dis. 2011;11:1\u20138.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"25075_CR22","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.5588\/ijtld.12.0848","volume":"17","author":"T Shimazaki","year":"2013","unstructured":"Shimazaki T, et al. Risk factors for death among hospitalised tuberculosis patients in poor urban areas in Manila, the Philippines. Int J Tuberc Lung Dis. 2013;17(11):1420\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"25075_CR23","first-page":"2016","volume":"19","author":"X Wang","year":"2015","unstructured":"Wang X, et al. Survival and associated mortality risk factors among post-treatment pulmonary tuberculosis patients in the Northwest of China. Eur Rev Med Pharmacol Sci. 2015;19(11):2016\u201325.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"25075_CR24","unstructured":"Sterling T et al. Culture-negative TB is associated with increased mortality in HIV-infected persons. in Conference on Retroviruses and Opportunistic Infections. 2015."},{"issue":"1","key":"25075_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4314\/ejhs.v27i1.4S","volume":"27","author":"AM Teklu","year":"2017","unstructured":"Teklu AM, et al. Factors associated with mortality of TB\/HIV co-infected patients in Ethiopia. Ethiop J Health Sci. 2017;27(1):29\u201338.","journal-title":"Ethiop J Health Sci"},{"issue":"8","key":"25075_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159925","volume":"11","author":"T Rodrigo","year":"2016","unstructured":"Rodrigo T, et al. Factors associated with fatality during the intensive phase of anti-tuberculosis treatment. PLoS ONE. 2016;11(8):e0159925.","journal-title":"PLoS ONE"},{"key":"25075_CR27","doi-asserted-by":"crossref","unstructured":"Gebremichael SG, Fenta SM. Factors associated with U5m in the afar region of Ethiopia. Advances in Public Health. 2020;2020:1\u20139.","DOI":"10.1155\/2020\/6720607"},{"issue":"07","key":"25075_CR28","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3855\/jidc.5963","volume":"9","author":"E Ejeta","year":"2015","unstructured":"Ejeta E, et al. Outcome of tuberculosis patients under directly observed short course treatment in Western Ethiopia. J Infect Dev Ctries. 2015;9(07):752\u20139.","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"25075_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijtb.2017.05.001","volume":"66","author":"S Abedi","year":"2019","unstructured":"Abedi S, et al. Determinant factors for mortality during treatment among tuberculosis patients: cox proportional hazards model. Indian J Tuberc. 2019;66(1):39\u201343.","journal-title":"Indian J Tuberc"},{"key":"25075_CR30","doi-asserted-by":"crossref","unstructured":"Amante TD, Ahemed TA. Risk factors for unsuccessful tuberculosis treatment outcome (failure, default and death) in public health institutions, Eastern Ethiopia. Pan Afr Med J. 2015;20.","DOI":"10.11604\/pamj.2015.20.247.3345"},{"issue":"4","key":"25075_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.26719\/2015.21.4.287","volume":"21","author":"M Moosazadeh","year":"2015","unstructured":"Moosazadeh M, et al. Predictive factors of death in patients with tuberculosis: a nested case-control study. East Mediterr Health J. 2015;21(4):287\u201392.","journal-title":"East Mediterr Health J"},{"key":"25075_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2238-7","volume":"17","author":"Y Sinshaw","year":"2017","unstructured":"Sinshaw Y, et al. Successful TB treatment outcome and its associated factors among TB\/HIV co-infected patients attending Gondar university referral Hospital, Northwest ethiopia: an institution based cross-sectional study. BMC Infect Dis. 2017;17:1\u20139.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"25075_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-093797","volume":"15","author":"LK Gedefa","year":"2025","unstructured":"Gedefa LK, et al. Predictive factors associated with virological failure among adult patients living with HIV on first-line highly active antiretroviral therapy in Southeast Oromia, ethiopia: a case\u2013control study. BMJ Open. 2025;15(4):e093797.","journal-title":"BMJ Open"},{"issue":"4","key":"25075_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.bjid.2018.07.002","volume":"22","author":"R Gayoso","year":"2018","unstructured":"Gayoso R, et al. Predictors of mortality in multidrug-resistant tuberculosis patients from Brazilian reference centers, 2005 to 2012. Braz J Infect Dis. 2018;22(4):305\u201310.","journal-title":"Braz J Infect Dis"},{"issue":"2","key":"25075_CR35","first-page":"64","volume":"55","author":"M Vasantha","year":"2008","unstructured":"Vasantha M, Gopi P, Subramani R. Survival of tuberculosis patients treated under DOTS in a rural tuberculosis unit (TU), South India. Indian J Tuberc. 2008;55(2):64\u20139.","journal-title":"Indian J Tuberc"},{"issue":"02","key":"25075_CR36","first-page":"45","volume":"5","author":"M Haile Workneh","year":"2016","unstructured":"Haile Workneh M, Aksel Bjune G, Abebe S, Yimer. Diabetes mellitus is associated with increased mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients in South-Eastern Amahra Region, Ethiopia. Infect Dis Poverty. 2016;5(02):45\u201354.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"25075_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1473-3099(19)30518-3","volume":"20","author":"OT Ranzani","year":"2020","unstructured":"Ranzani OT, et al. Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in S\u00e3o Paulo state, Brazil, 2010\u201315: a population-based, longitudinal study. Lancet Infect Dis. 2020;20(1):123\u201332.","journal-title":"Lancet Infect Dis"},{"key":"25075_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3844\/ajidsp.2018.69.76","volume":"14","author":"CB Fotso","year":"2018","unstructured":"Fotso CB, Vasaikar SD, Apalata T. Outcomes and risk factors associated with drug-resistant tuberculosis in rural Eastern Cape, South Africa. Am J Infect Dis. 2018;14:69\u201376.","journal-title":"Am J Infect Dis"},{"issue":"2","key":"25075_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-080144","volume":"14","author":"MH Suhairi","year":"2024","unstructured":"Suhairi MH, et al. Risk factors for tuberculosis-related death among adults with drug-sensitive pulmonary tuberculosis in Selangor, Malaysia from 2013 to 2019: a retrospective cohort study using surveillance data. BMJ Open. 2024;14(2):e080144.","journal-title":"BMJ Open"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25075-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:10:16Z","timestamp":1762884616000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-25075-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25075"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25075-z","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved from the department review board (DRB) of the Hawassa University department of statistics with reference number (Ref.No. Stat\/060\/15), which granted a waiver of informed consent given the retrospective nature of the study and the use of anonymized medical records. The information gathered from the patient file will be handled with confidence. The programming of data extraction tools avoids the display of names and other private information. The Declaration of Helsinki\u2019s guiding principles were followed during the study\u2019s execution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No individual person\u2019s personal details, images, or videos are being used in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3881"}}